RESUMO
Objective@#To expand the scope of the work performed by emergency medical service (EMS) providers, a 3-day education training course was implemented at the national level to organize and operate a special EMS unit consisting of level-1 EMS providers and nurses. We conducted an evaluation of the curriculum for EMS providers that completed the education course. @*Methods@#From June 2019 to July 2020, a survey was conducted to evaluate the curriculum of 270 EMS providers that completed the training course in Gangwon province. We analyzed differences between educational needs, satisfaction with educational contents, and job performance confidence with respect to age, sex, certification, and career. @*Results@#We analyzed the contents of 143 questionnaires received from the EMS providers. Satisfaction with the “instructor” was highest at 4.52 points, and satisfaction with the “education” provided was lowest at 3.89 points. Those aged over 40 had the highest satisfaction scores for “education”, and a significant inverse relationship was found between age and satisfaction (P=0.020). In the overall curriculum, educational need was highest among those with a career duration of ≥ 3 years and those in their 30s. Regarding educational contents, the need for advanced cardiovascular resuscitation was greatest and the need for emergency delivery was lowest, but this difference was not significant. @*Conclusion@#When designing a curriculum for EMS providers in the future, segregation into similar groups is required to reflect their educational needs.
RESUMO
BACKGROUND: The safety and clinical effectiveness data of peramivir in the real clinical field are limited. A prospective observational study was conducted based on the post-marketing surveillance data to evaluate the post-marketing safety and effectiveness of peramivir in Korean adults with seasonal influenza. METHODS: Among adults aged 20 years or older who were diagnosed with influenza A or B, patients who started peramivir within 48 hours from the initial symptoms of influenza were enrolled. All adverse events (AEs) that occurred within 7 days after administration of peramivir were checked. For the evaluation of effectiveness, changes in the severity of influenza symptoms and daily living performance were examined before and 7 days after the administration of peramivir. The date on which influenza related symptoms disappeared was checked. RESULTS: A total of 3,024 patients were enrolled for safety evaluation and 2,939 patients were for effectiveness evaluation. In the safety evaluation, 42 AEs were observed in 35 (1.16%) patients. The most common AE was fever. AEs were mostly rated as mild in severity. Serious AEs were observed in 10 patients and two of them died. However, both deaths were considered to be less relevant to peramivir. In the effectiveness evaluation, the severity of influenza symptoms decreased by 10.68 ± 4.01 points and daily living performance was improved 5.59 ± 2.16 points. Influenza related symptoms disappeared on average 3.02 ± 2.39 days after peramivir administration. CONCLUSION: Peramivir showed a tolerable safety profile and acceptable effectiveness in Korean adult patients with seasonal influenza.